BioSpace News Archive

What happens in the final moments of a job interview is probably one of the most overlooked aspects of the entire job seeking or hiring process, and how you conduct yourself at these critical final moments can sway the offer in your favor (or out of it), especially if you’re in tight competition with other highly-qualified applicants.

Evotec AG announced today that its management will be presenting and attending the following upcoming conferences:

TxCell SA today reports its financial information for the 3rd quarter of 2018.

2018 scale-up of Biom’up’s manufacturing facility near Lyon (France) completed, allowing for a larger throughput and increased shipments of devices to the US and EU markets

Auris Medical Holding AG today announced that it will provide a business update and report its financial results for the third quarter of 2018 on Thursday, November 15, 2018.

Potential new immune-oncology therapy uses antibody drug conjugate (ADC) that targets regulatory T cells (Tregs)

Quality certification means that the management system meets the requirements imposed by International Standard ISO 9001:2015. The certification covers product development, production and sales.

Esperion today announced that the company will participate in analyst-led fireside chats with investors at the following conferences:

FDA-Approved Study Furthers Medtronic Commitment to Generate Meaningful Clinical Evidence for Use of Renal Denervation to Treat Uncontrolled Hypertension

Karyopharm Therapeutics Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to selinexor, the Company’s first in class, oral SINE compound, for the treatment of patients with diffuse large B-cell lymphoma (DLBCL) who have received at least two prior therapies and are not eligible for high dose chemotherapy with stem cell rescue or CAR-T therapy.